ADIPOQ and acute myocardial infarction: A meta-analysis showed that increased plasma levels of adiponectin related to a high risk of mortality in subjects with CVD [40], while another study reported that high plasma adiponectin levels at discharge were associated with all-cause mortality during the 11.6 years follow-up in patients with acute myocardial infarction [41].